How should a patient receiving a continuous intravenous infusion of regular human insulin be transitioned to subcutaneous insulin glargine with pre‑meal rapid‑acting insulin boluses?

Transitioning from IV Insulin to Subcutaneous Glargine with Prandial Boluses

Administer subcutaneous insulin glargine immediately when stopping the IV insulin infusion, using 50% of the total 24-hour IV insulin dose as basal glargine, with the remaining 50% divided as rapid-acting insulin boluses before meals. 1

Pre-Transition Requirements

Before initiating the transition, ensure the following conditions are met:

• Blood glucose stability: Maintain glucose levels ≤180 mg/dL (10 mmol/L) for at least 24 hours on IV insulin 1
• IV insulin infusion rate: Should be <3 units/hour; rates ≥5 units/hour indicate significant insulin resistance and warrant delaying transition 1
• Nutritional status: Patient should have resumed oral feeding or have predictable enteral/parenteral nutrition 1
• Clinical stability: Patient should be hemodynamically stable, off vasopressors, and without significant peripheral edema 1

Calculating the Transition Dose

Primary Method (Most Widely Used)

Calculate the total 24-hour IV insulin requirement from the stable infusion rate over the preceding 24 hours 1:

• Basal insulin (glargine): 50% of total 24-hour IV insulin dose 1
• Prandial insulin (rapid-acting): Remaining 50% divided among meals based on carbohydrate content 1

Alternative Method (More Conservative)

Some guidelines recommend 80% of the 24-hour IV insulin dose as basal glargine, with rapid-acting insulin added at the first meal 1. However, the 50/50 split is the most widely validated approach 1.

For Short-Duration IV Insulin (<24 hours)

In insulin-naïve patients who received IV insulin for <24 hours with persistent postoperative hyperglycemia 1:

• Start with 0.5-1 unit/kg total daily dose
• Split equally: 50% basal glargine, 50% rapid-acting insulin
• Give only half the anticipated prandial dose if oral intake is light

Timing of Administration

Critical timing considerations to prevent rebound hyperglycemia:

• Administer glargine immediately when stopping the IV insulin infusion 1
• Optimal transition time: 20:00 hours (8 PM) 1
• If transitioning before 20:00 hours, adjust the dose proportionally and give the second full dose at 20:00 hours 1
• Do NOT stop IV insulin before giving subcutaneous glargine - this creates a dangerous insulin-deficient period 1
• For patients transitioning from DKA management, give basal insulin 2-4 hours before stopping IV insulin to prevent ketoacidosis recurrence 1

Prandial Insulin Dosing

Administer rapid-acting insulin (lispro, aspart, or glulisine) before each meal:

• Start with 1 unit per 10-15 grams of carbohydrate 1
• Adjust based on carbohydrate content of each meal 1
• Give first prandial dose at the first meal after transition 1
• If meal is light, give only 50% of the calculated prandial dose 1

Monitoring and Adjustment

Intensive glucose monitoring is essential during transition:

• Check blood glucose before each meal, at bedtime, and every 4-6 hours if NPO 1
• Target range: 80-180 mg/dL (4.4-10.0 mmol/L) for most patients 1
• Add correction doses of rapid-acting insulin for hyperglycemia 1
• Adjust basal and prandial doses daily based on glucose patterns 1

Common Pitfalls and Safety Considerations

Avoid these critical errors:

• Never use sliding-scale insulin alone - this approach is strongly discouraged and associated with worse outcomes 1
• Do not stop oral antidiabetic agents abruptly when starting insulin, as this causes rebound hyperglycemia 2
• Discontinue sulfonylureas/meglitinides once prandial insulin is initiated to prevent hypoglycemia 1
• Monitor for hypoglycemia (<60 mg/dL or 3.3 mmol/L) and treat immediately with glucose 1
• Screen for ketosis if glucose exceeds 300 mg/dL (16.5 mmol/L) in insulin-treated patients 1

Special Populations

For patients previously on insulin pumps:

• Reconnect pump only when patient can manage autonomously 1
• If not autonomous, initiate basal-bolus regimen immediately after stopping IV insulin 1
• Use the pump's 24-hour basal rate to calculate equivalent glargine dose 1

For patients on enteral/parenteral nutrition:

• Continuous enteral feeding: 50% of 24-hour IV insulin as glargine is adequate 3
• Total parenteral nutrition: May require 80% of IV insulin dose as basal, with 41% dose increase often needed in first 3 days 3

Evidence Quality

The basal-bolus regimen significantly improves glycemic control and reduces postoperative complications compared to sliding-scale insulin alone 1. The 50/50 split method (Avanzini model) represents the most widely validated transition approach 1, though the 80% basal method is a reasonable alternative for patients with higher insulin requirements 1, 4.